Cargando…

Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland

IMPORTANCE: Vaccine responses are decreased in solid organ transplant (SOT) recipients, and given the complexity of implementation, vaccination programs may be suboptimal. The actual burden of vaccine-preventable infections (VPIs) among SOT recipients remains unclear. OBJECTIVES: To assess the incid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walti, Laura N., Mugglin, Catrina, Mombelli, Matteo, Manuel, Oriol, Hirsch, Hans H., Khanna, Nina, Mueller, Nicolas J., Berger, Christoph, Boggian, Katia, Garzoni, Christian, Neofytos, Dionysios, van Delden, Christian, Mäusezahl, Mirjam, Hirzel, Cédric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148200/ https://www.ncbi.nlm.nih.gov/pubmed/37115546 http://dx.doi.org/10.1001/jamanetworkopen.2023.10687

Ejemplares similares

Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study
por: Walti, Laura N., et al.
Publicado: (2020)

Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients
por: van den Bogaart, Lorena, et al.
Publicado: (2021)

Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018
por: Kohler, Philipp, et al.
Publicado: (2021)

Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update
por: Neofytos, Dionysios, et al.
Publicado: (2023)

Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients
por: Pham, Truong‐Thanh, et al.
Publicado: (2022)

Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study
por: van Delden, Christian, et al.
Publicado: (2020)

Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation
por: Schreiber, Peter W., et al.
Publicado: (2018)

Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates
por: Sava, Mihaela, et al.
Publicado: (2022)

Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland
por: Coste, A. T., et al.
Publicado: (2020)

Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro
por: Tschan-Plessl, Astrid, et al.
Publicado: (2016)

Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients
por: Olearo, Flaminia, et al.
Publicado: (2020)

Impact of different urinary tract infection phenotypes within the first year post‐transplant on renal allograft outcomes
por: Brune, Jakob E., et al.
Publicado: (2022)

Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey
por: Adam, Kai-Manuel, et al.
Publicado: (2021)

Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients
por: Royston, Léna, et al.
Publicado: (2021)

Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study
por: Royston, Léna, et al.
Publicado: (2021)

Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
por: Robert-Gangneux, Florence, et al.
Publicado: (2018)

A tradition and an epidemic: determinants of the campylobacteriosis winter peak in Switzerland
por: Bless, Philipp Justus, et al.
Publicado: (2014)

Cohort profile: The Swiss Transplant Cohort Study (STCS): A nationwide longitudinal cohort study of all solid organ recipients in Switzerland
por: Stampf, Susanne, et al.
Publicado: (2021)

CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients
por: Chavaz, Lara, et al.
Publicado: (2023)

When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?
por: Roth, Romain Samuel, et al.
Publicado: (2022)

Risk factors for candidemia: a prospective matched case-control study
por: Poissy, Julien, et al.
Publicado: (2020)

Antimicrobial stewardship programs in solid‐organ transplant recipients in Switzerland
por: Bielicki, Julia A., et al.
Publicado: (2022)

Distinct Clinical and Laboratory Patterns of Pneumocystis jirovecii Pneumonia in Renal Transplant Recipients
por: Meyer, Andreas M. J., et al.
Publicado: (2021)

Marked increase in measles vaccination coverage among young adults in Switzerland: a campaign or cohort effect?
por: Altpeter, Ekkehardt, et al.
Publicado: (2018)

Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?
por: Roth, Romain Samuel, et al.
Publicado: (2021)

Testing for Chlamydia trachomatis: time trends in positivity rates in the canton of Basel-Stadt, Switzerland
por: SCHMUTZ, C., et al.
Publicado: (2013)

Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals
por: Ragozzino, Silvio, et al.
Publicado: (2021)

Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections
por: Roth, Romain Samuel, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Royston, Léna, et al.
Publicado: (2022)

Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients
por: Atamna, Alaa, et al.
Publicado: (2023)

Clinical Considerations of Isavuconazole Administration in High-Risk Hematological Patients: A Single-Center 5-Year Experience
por: Kronig, Ilona, et al.
Publicado: (2021)

The burden of gastroenteritis in Switzerland (BUGS) study: a research proposal for a 1-year, prospective cohort study
por: Schmutz, Claudia, et al.
Publicado: (2018)

National point prevalence survey on healthcare-associated infections in acute care hospitals, Switzerland, 2017
por: Zingg, Walter, et al.
Publicado: (2019)

Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study
por: Hirzel, Cédric, et al.
Publicado: (2015)

Human papillomavirus vaccine uptake in adolescence and adherence to cervical cancer screening in Switzerland: a national cross-sectional survey
por: Wymann, Monica N., et al.
Publicado: (2017)

Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma
por: Zanella, Marie-Céline, et al.
Publicado: (2023)

Estimating healthcare costs of acute gastroenteritis and human campylobacteriosis in Switzerland
por: SCHMUTZ, C., et al.
Publicado: (2017)

Methods to systematically review and meta-analyse observational studies: a systematic scoping review of recommendations
por: Mueller, Monika, et al.
Publicado: (2018)

Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation
por: Glampedakis, Emmanouil, et al.
Publicado: (2021)

The HIV Care Cascade from HIV diagnosis to viral suppression in sub-Saharan Africa: a systematic review and meta-regression analysis protocol
por: Gueler, Aysel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v95q482iqkgpocmeeldtg7hdfk